* indicates required field
Length: 15
Source of Standard: AJCC
Section Name: Stage/Prognostic Factors
Year Implemented: 2021
Version Implemented: 21
Record Types:
A
,
M
,
C
,
I
XML NAACCR ID: ajccTnmPostTherapyClinT
Parent XML Element: Tumor
Required Status:
NPCR Collect: . - No recommendations
CoC Collect: R - Required
SEER Collect: RC - Collected by SEER from CoC-accredited hospitals
CCCR Collect: . - No recommendations
Description:
Detailed site-specific codes for the post therapy clinical (yc) tumor (T) as defined by AJCC.
Clinical, pathological, and post therapy yc and yp stage data are given four separate areas in the NAACCR Data Exchange Record Layout.
Rationale:
CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.
Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known following the completion of neoadjuvant therapy (satisfying the definition for that disease site) before planned surgical resection or primary treatment consisting of systemic and/or radiation therapy.
Item Data Type:
text
Allowable Values
Those published in the AJCC Cancer Staging Manual, 88, blank
Codes:
In addition to those published in the AJCC Cancer Staging Manual
88 |
Not applicable, no code assigned for this case in the current AJCC Staging Manual. |
|---|---|
Blank |
This field is left blank if no information at all is available to code this item. |
Code Notes:
Note: See the AJCC Cancer Staging Manual, current edition for site-specific categories for the TNM categories and stage groups. See the CURRENT STORE manual for specifications for codes and data entry rules.